NOVT

Novanta Inc

Add to Watchlist

Advanced Chart

118.250

+5.11(4.517%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

118.300

Open

114.340

VWAP

117.07

Vol

49.21K

Mkt Cap

4.07B

Low

114.340

Amount

5.76M

EV/EBITDA(TTM)

24.14

Total Shares

35.97M

4.42B

EV/OCF(TTM)

33.67

P/S(TTM)

4.27

Novanta Inc. is a supplier of core technology solutions, which offer medical and advanced industrial original equipment manufacturers. Its segment includes Automation Enabling Technologies and Medical Solutions. The Automation Enabling Technologies segment designs, manufactures and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles to customers worldwide. The Medical Solutions segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators and endoscopic pumps and related disposables, laser beam delivery solutions, video processing and streaming and capture, machine vision technologies, radio frequency identification (RFID) technologies, thermal chart recorders, and others.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

FY2025Q2

255.17M

+7.19%

0.940

+23.68%

245.95M

+0.63%

0.817

-3.92%

237.97M

+0.89%

0.733

+0.46%

Estimates Revision

The market is revising No Change the revenue expectations for Novanta Inc. (NOVT) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -10.20%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-10.20%

In Past 3 Month

3 Analyst Rating

16.28% Upside

Wall Street analysts forecast NOVT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NOVT is 137.50 USD with a low forecast of 136.00 USD and a high forecast of 139.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

2 Hold

0 Sell

Moderate Buy

16.28% Upside

Current: 118.250

Low

136.00

Averages

137.50

High

139.00

16.28% Upside

Current: 118.250

Low

136.00

Averages

137.50

High

139.00

Baird

Neutral

downgrade

$139 -> $133

2025-08-11

New

Reason

Baird

Price Target

$139 -> $133

2025-08-11

New

downgrade

Neutral

Reason

Baird lowered the firm's price target on Novanta to $133 from $139 and keeps a Neutral rating on the shares. The firm updated its model as it believes the sales bottom looks in place and the outlook for 2026 looks potentially favorable.

Baird

Neutral

downgrade

$160 -> $139

2025-05-12

Reason

Baird

Price Target

$160 -> $139

2025-05-12

downgrade

Neutral

Reason

Baird lowered the firm's price target on Novanta to $139 from $160 and keeps a Neutral rating on the shares. The firm updated its model following mixed Q1 results where they lowered estimates but see bright spots beginning to appear.

Baird

Robert Mason

Hold

Maintains

$169 → $160

2025-03-03

Reason

Baird

Robert Mason

Price Target

$169 → $160

2025-03-03

Maintains

Hold

Reason

Baird analyst Robert Mason lowered the firm's price target on Novanta to $160 from $169 and keeps a Neutral rating on the shares. The firm The firm updated its model following its mixed Q4 report. New products are driving the 2025 outlook which with upside possible if markets rebound.

Baird

Robert Mason

Hold

Maintains

$175 → $169

2024-11-06

Reason

Baird

Robert Mason

Price Target

$175 → $169

2024-11-06

Maintains

Hold

Reason

Baird analyst Robert Mason lowered the firm's price target on Novanta to $169 from $175 and keeps a Neutral rating on the shares. The firm said discrete customer decisions to defer ramps on new product intros, combined with capital goods demand softnes at year-end 2024 all contributing to revisions.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Novanta Inc (NOVT.O) is 32.35, compared to its 5-year average forward P/E of 48.79. For a more detailed relative valuation and DCF analysis to assess Novanta Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Strongly Undervalued

5Y Average PE

48.79

Current PE

32.35

Overvalued PE

55.83

Undervalued PE

41.76

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Strongly Undervalued

5Y Average EV/EBITDA

29.28

Current EV/EBITDA

19.25

Overvalued EV/EBITDA

33.45

Undervalued EV/EBITDA

25.10

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Strongly Undervalued

5Y Average PS

6.03

Current PS

4.12

Overvalued PS

6.83

Undervalued PS

5.22